通用幹細胞 - 通用幹細胞股份有限公司

2023-03-16

News-1

The prevalence rate of degenerative knee arthritis in the Chinese population is about 15%, and 3.5 million people suffer from joint pain. Osteoarthritis is the number […]

2023-01-05

Treating Osteoarthritis Without Surgery! Bring you back to a lively life

Osteoarthritis is an arch-enemy of the elders. The prevalence rate of knee osteoarthritis in Taiwan is about 15%, and over 3.5 million people suffer from joint […]

2023-01-05

A revolutionary new treatment for osteoarthritis published in an international journal

Professor Su Honglin from the Department of Life Sciences of Chung Hsing University said that type II collagen protein is the main component of articular cartilage. […]

2022-12-31

Enriched Peripheral Blood-Derived Mononuclear Cells for Treating Knee Osteoarthritis

Osteoarthritis is the main chronic bone disease of the elderly. At present, there is no treatment for osteoarthritis that can reverse the disease. The main research […]

2022-12-16

Induction of type II collagen expression in M2 macrophages derived from peripheral blood mononuclear cells

The human type II collagen (Col II), specifcally expressed in chondrocytes, is a crucial component of the adult hyaline cartilage. We examine the potential of artifcial […]

2022-12-16

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Immune checkpoint inhibitors and targeted therapies have dramatically improved outcomes in patients with advanced melanoma, but approximately half these patients will not have a durable benefit. […]

2022-05-16

An 80-year-old elder suffered from osteoarthritis which made him can barely walk. ‘Enriched peripheral blood mononuclear cell therapy’ helps him recover

Mr. Lin lives in Tainan, Taiwan. He is over 80 years old but he’s still hale and hearty. He usually goes out and goes mountain hiking, […]